Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-05

Clinical Trial Update: A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol [Phase 1]

View source ↗

Summary

Phase 1 trial of LY3015014 in healthy participants with elevated LDL cholesterol has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3015014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hyperlipidemia | Phase 1 | Status: COMPLETED | Results posted: 2019-04-05